Search research articles
Contact Us
Filters
Showing results (1-10 of 33) with videos related to
Page
of 4
Sort By:
Lancet (London, England)
|
August 21, 2012
New cellular and molecular mechanisms of lung injury and fibrosis in idiopathic pulmonary fibrosis
Isis E Fernandez, Oliver Eickelberg
Proceedings of the American Thoracic Society
|
July 18, 2012
The impact of TGF-β on lung fibrosis: from targeting to biomarkers
Isis E Fernandez, Oliver Eickelberg
European Respiratory Review : an Official Journal of the European Respiratory Society
|
September 29, 2017
Systems medicine advances in interstitial lung disease
Flavia R Greiffo, Oliver Eickelberg, Isis E Fernandez
Annals of the American Thoracic Society
|
April 2, 2015
Characteristic patterns in the fibrotic lung. Comparing idiopathic pulmonary fibrosis with chronic lung allograft dysfunction
Isis E Fernandez, Katharina Heinzelmann, Stijn Verleden, et al.
American Journal of Respiratory Cell and Molecular Biology
|
May 6, 2016
Immune Mechanisms in Pulmonary Fibrosis
Saeed Kolahian, Isis E Fernandez, Oliver Eickelberg, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
March 3, 2017
Detecting Swelling States of Red Blood Cells by "Cell-Fluid Coupling Spectroscopy"
Carla Zensen, Isis E Fernandez, Oliver Eickelberg, et al.
British Journal of Pharmacology
|
July 1, 2026
Targeting KRAS for cancer therapy
Jianlong Jia, Ruonan Liu, Tonia A Adamide, et al.
Histochemistry and Cell Biology
|
December 10, 2015
Pharmacokinetic and pharmacometabolomic study of pirfenidone in normal mouse tissues using high mass resolution MALDI-FTICR-mass spectrometry imaging
Na Sun, Isis E Fernandez, Mian Wei, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology
|
March 20, 2016
Systematic phenotyping and correlation of biomarkers with lung function and histology in lung fibrosis
Isis E Fernandez, Oana V Amarie, Kathrin Mutze, et al.
Plos One
|
September 5, 2015
Validation of the 2nd Generation Proteasome Inhibitor Oprozomib for Local Therapy of Pulmonary Fibrosis
Nora Semren, Nunja C Habel-Ungewitter, Isis E Fernandez, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 33) with videos related to
Sort By:
Page
of 4
Lancet (London, England)
|
August 21, 2012
New cellular and molecular mechanisms of lung injury and fibrosis in idiopathic pulmonary fibrosis
Isis E Fernandez, Oliver Eickelberg
Proceedings of the American Thoracic Society
|
July 18, 2012
The impact of TGF-β on lung fibrosis: from targeting to biomarkers
Isis E Fernandez, Oliver Eickelberg
European Respiratory Review : an Official Journal of the European Respiratory Society
|
September 29, 2017
Systems medicine advances in interstitial lung disease
Flavia R Greiffo, Oliver Eickelberg, Isis E Fernandez
Annals of the American Thoracic Society
|
April 2, 2015
Characteristic patterns in the fibrotic lung. Comparing idiopathic pulmonary fibrosis with chronic lung allograft dysfunction
Isis E Fernandez, Katharina Heinzelmann, Stijn Verleden, et al.
American Journal of Respiratory Cell and Molecular Biology
|
May 6, 2016
Immune Mechanisms in Pulmonary Fibrosis
Saeed Kolahian, Isis E Fernandez, Oliver Eickelberg, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
March 3, 2017
Detecting Swelling States of Red Blood Cells by "Cell-Fluid Coupling Spectroscopy"
Carla Zensen, Isis E Fernandez, Oliver Eickelberg, et al.
British Journal of Pharmacology
|
July 1, 2026
Targeting KRAS for cancer therapy
Jianlong Jia, Ruonan Liu, Tonia A Adamide, et al.
Histochemistry and Cell Biology
|
December 10, 2015
Pharmacokinetic and pharmacometabolomic study of pirfenidone in normal mouse tissues using high mass resolution MALDI-FTICR-mass spectrometry imaging
Na Sun, Isis E Fernandez, Mian Wei, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology
|
March 20, 2016
Systematic phenotyping and correlation of biomarkers with lung function and histology in lung fibrosis
Isis E Fernandez, Oana V Amarie, Kathrin Mutze, et al.
Plos One
|
September 5, 2015
Validation of the 2nd Generation Proteasome Inhibitor Oprozomib for Local Therapy of Pulmonary Fibrosis
Nora Semren, Nunja C Habel-Ungewitter, Isis E Fernandez, et al.
Page
of 4